Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1990;10:658-664

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Russell, J. C.
Right arrow Articles by Amy, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Russell, J. C.
Right arrow Articles by Amy, R. M.

Arteriosclerosis, Vol 10, 658-664, Copyright © 1990 by American Heart Association


ARTICLES

Prevention of myocardial lesions in JCR:LA-corpulent rats by nifedipine

JC Russell, DG Koeslag, PJ Dolphin and RM Amy
Department of Surgery, University of Alberta, Edmonton, Canada.

Male rats of the JCR:LA-corpulent strain spontaneously develop atherosclerosis and myocardial lesions if corpulent. The corpulent rats exhibit a marked very low density hyperlipidemia and insulin resistance. The incidence of both vascular and myocardial lesions correlates strongly with the hyperinsulinemia, but not with the hyperlipidemia. Corpulent male rats were chronically treated with nifedipine or acetylsalicylic acid to explore the roles of smooth muscle spasm and platelet activity in induction of the myocardial lesions. Acetylsalicylic acid treatment was associated with no significant changes in fasting glucose, insulin, or lipid concentrations. Nifedipine caused no significant changes in glucose concentration but was associated with mildly increased insulin levels. Treatment with nifedipine resulted in significant decreases in serum triglyceride concentrations. The decreases were confined to longer- chain triacylglycerol molecular species with no change in the concentration of molecular species with 48 or 50 acyl carbon atoms. There was no effect on myocardial lesion frequency with acetylsalicylic acid treatment. In contrast, nifedipine prevented the development of old organized scarred lesions. This effect is similar to that seen with treatments that markedly reduce the insulin resistance. These findings suggest that platelet-initiated thrombus formation is not an important factor in lesion formation in the JCR:LA-cp rat, but that smooth muscle spasm is probably important.


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. L. Atkinson, R. Kozak, S. E. Kelly, A. Onay-Besikci, J. C. Russell, and G. D. Lopaschuk
Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats
Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E923 - E930.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Misra, J. S. C. Gilchrist, J. C. Russell, and G. N. Pierce
Cardiac myofibrillar and sarcoplasmic reticulum function are not depressed in insulin-resistant JCR:LA-cp rats
Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H1811 - H1817.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. C. Russell, R. M. Amy, S. E. Graham, P. J. Dolphin, G. O. Wood, and J. Bar-Tana
Inhibition of Atherosclerosis and Myocardial Lesions in the JCR:LA-cp Rat by ß,ß'-Tetramethylhexadecanedioic Acid (MEDICA 16)
Arterioscler. Thromb. Vasc. Biol., July 1, 1995; 15(7): 918 - 923.
[Abstract] [Full Text]